Overview

Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease

Status:
Completed
Trial end date:
2020-09-15
Target enrollment:
Participant gender:
Summary
Clinical Trial Evaluating the Safety and Tolerability of ALY688 in Subjects with Dry Eye Disease
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Allysta Pharmaceutical
Treatments:
Ophthalmic Solutions
Pharmaceutical Solutions